BioNTech vs Centivax
BioNTech vs Centivax, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioNTech is on 66/100 and Centivax on 45/100.
Where each one leads
BioNTech
- our overall score: 66/100 against 45/100
- domain rating: 74/100 against 36/100
- headcount: 5,128 against 31
- LinkedIn following: 295,812 against 5,340
Centivax
- agent readiness: 46/100 against 40/100
At a glance
| Measure | BioNTech | Centivax |
|---|---|---|
| What it is | Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases. | Accelerating the world’s transition to a post-pathogen humanity. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, Vaccines, Infectious Diseases |
| Sells toBusiness model | B2B | B2G |
| Offering | Biotechnology | Services |
| Founded | 2008 | Not published |
| Headquarters | Mainz, Germany | South San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | BioNTech | Centivax |
|---|---|---|
| Employees | 5,128 | 31 |
| Total funding | $975M | Not published |
| Latest round | Loan | Funding Round |
| LinkedIn followers | 295,812 | 5,340 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioNTech | Centivax |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 45/100 |
| Traction | 60/100 | 15/100 |
| Team | 70/100 | 30/100 |
| Community | Not published | 8/100 |
| Search visibility | 35/100 | 32/100 |
| Quality | 78/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (46/100) |
| Domain ratingLink authority, 0-100 | 74/100 | 36/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioNTech | Centivax |
|---|---|---|
| Hosting | Azure | Not detected |
| CMS | Not detected | Squarespace |
| Analytics | Google Tag Manager | Not detected |
BioNTech vs Centivax: common questions
Which is better, BioNTech or Centivax?
On our 0-100 score BioNTech rates higher (66/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do BioNTech and Centivax compare on the numbers?
BioNTech leads on our overall score (66/100 against 45/100), domain rating (74/100 against 36/100), headcount (5,128 against 31), LinkedIn following (295,812 against 5,340). Centivax leads on agent readiness (46/100 against 40/100).
Read the full BioNTech review and pricing or the Centivax review and pricing. You can also browse other BioNTech alternatives we track.